To define the genes and pathways associated with GJB2 or SCN9A knockdown, we jointly analyzed the four gene lists from patient-derived GBM cells and patient GBMs to identify integrative pathway enrichments using the ActivePathways method (Paczkowska et al, 2020). This evidence concerns the gene GJB2 and glioblastoma.